Company overview
Lee Pharma Limited
CIN
U24230TG1997PLC028095
Name
Lee Pharma Limited
Entity type
Public
Paid up capital
₹16,443,610
Authorized capital
₹76,500,000
Industry name
Manufacturing (Metals and Chemicals, and products thereof)
Registry
ROC Hyderabad
Status
Active
Incorporation date
6 October 1997
Address
Survey No.257&258/1, Door No.11-6/56, C Block, Opp.Idpl Factory, Moosapet(village), Balan, Agar(post), Hyderabad, Hyderabad, Telangana
Postal code
500037
Country
India
Primary goods traded
- 78.8% — Heterocyclic compounds (293399)
- 11.3% — Nucleic acids and their salts, other heterocyclic compounds, n.e.c. in heading number 2934 (293499)
- 5.7% — Organic compounds (294200)
- 2.3% — Heterocyclic compounds (293339)
- 2.0% — Organic derivatives of hydrazine or of hydroxylamine (292800)
Directors
| Name | DIN | Designation | Join Date | Resign Date |
|---|---|---|---|---|
| Vijaykumar Raghunandanprasad Agrawal | 01710632 | Director | 27 September 2007 | |
| Venkata Reddy Alla | 00018534 | Managing Director | 6 October 1997 | |
| Dr Gopala Rao Tatineni | 00043939 | Director | 22 April 1999 | |
| Vishakha Bhupendra Dhablia | 07825815 | Director | 14 June 2018 | |
| Alla Ratna Kumari | 00022478 | Wholetime Director | 27 August 2007 | |
| Yogeswara Rao Danda | 00694803 | Director | 30 March 2015 | |
| Prabir Kumar Mishra | 05248954 | Additional Director | 20 March 2018 | 30 August 2018 |
| Raghumitra Alla | 00080789 | Wholetime Director | 4 May 2006 |
Main Trading Partners
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Trade Data
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 30 April 2022 | IN | 29339990 | (1S,3s,5s)-3-(aminocarbonyl)-2-Azabicyclo[3,1,0]hexane-2-Carboxylic Acid Tert-Butyl Ester | Lee Pharma Limited | IN | Zhejiang Shindai Chemicals Company Limited | $516,600.00 | |
| 12 May 2022 | IN | 29339990 | (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-Tetrahydro-1,2,4-Triazolo[4,3,a]pyrazin-7-Yl]-4-(2,4,5-Trifluorophenyl)butan | Lee Pharma Limited | IN | Anhui Cheer Our Medical Technology Company Limited | $385,815.70 | |
| 30 April 2022 | IN | 29339990 | (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-Tetrahydro-1,2,4-Triazolo[4,3,a]pyrazin-7-Yl]-4-(2,4,5-Trifluorophenyl)butan | Lee Pharma Limited | IN | Anhui Cheer Our Medical Technology Company Limited | $385,315.61 | |
| 28 March 2022 | IN | 29339990 | (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-Tetrahydro-1,2,4-Triazolo[4,3,a]pyrazin-7-Yl]-4-(2,4,5-Trifluorophenyl)butan | Lee Pharma Limited | IN | Anhui Cheer Our Medical Technology Company Limited | $331,282.50 | |
| 24 May 2022 | IN | 29339990 | (1S,3s,5s)-3-(aminocarbonyl)-2-Azabicyclo[3,1,0]hexane-2-Carboxylic Acid Tert-Butyl Ester | Lee Pharma Limited | IN | Zhejiang Shindai Chemicals Company Limited | $305,851.65 | |
| 4 March 2022 | IN | 29349990 | 2-((3Ar,4s,6r,6as)-6-Amino-2,2-Dimethyltetrahydro-3ah-Cyclopenta[d][1,3]dioxol-4-Yloxy)ethanol L-Tartaric Acid(1:1) | Lee Pharma Limited | IN | Zhejiang Shindai Chemicals Company Limited | $286,139.00 | |
| 7 April 2022 | IN | 29349990 | 2-((3Ar,4s,6r,6as)-6-Amino-2,2-Dimethyltetrahydro-3ah-Cyclopenta[d][1,3]dioxol-4-Yloxy)ethanol L-Tartaric Acid(1:1) | Lee Pharma Limited | IN | Zhejiang Shindai Chemicals Company Limited | $284,723.81 | |
| 29 July 2022 | IN | 29339990 | (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-Tetrahydro-1,2,4-Triazolo[4,3,a]pyrazin-7-Yl]-4-(2,4,5-Trifluorophenyl)butan | Lee Pharma Limited | IN | Anhui Cheer Our Medical Technology Company Limited | $262,000.00 | |
| 13 August 2022 | IN | 29339990 | (3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-Tetrahydro-1,2,4-Triazolo[4,3-A]pyrazin-7-Yl]-4-(2,4,5-Trifluorophenyl)butan | Lee Pharma Limited | IN | Anhui Cheer Our Medical Technology Company Limited | $258,000.00 | |
| 19 September 2022 | IN | 29349990 | 2-((3Ar,4s,6r,6as)-6-Amino-2,2-Dimethyltetrahydro-3ah-Cyclopenta[d][1,3]dioxol-4-Yloxy)ethanol L-Tartaric Acid(1:1) | Lee Pharma Limited | IN | Zhejiang Shindai Chemicals Company Limited | $246,400.00 |
0 of 20 row(s) selected.